Trial
NCT05953688
POC Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Active Intermediate, Posterior, or Pan NIU
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Alumis Inc
Collaborators
—
Condition
Uveitis Posterior Non-Infectious
Intervention
ESK-001
Why stopped
Terminated based on interim efficacy data that did not meet the Sponsor's criteria.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-08-28